Search Results - "Fack, Fred "
-
1
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Published in Proceedings of the National Academy of Sciences - PNAS (01-03-2011)“…Bevacizumab, an antibody against vascular endothelial growth factor (VEGF), is a promising, yet controversial, drug in human glioblastoma treatment (GBM). Its…”
Get full text
Journal Article -
2
Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways
Published in EMBO molecular medicine (01-12-2017)“…Heterozygous mutations in NADP‐dependent isocitrate dehydrogenases (IDH) define the large majority of diffuse gliomas and are associated with hypermethylation…”
Get full text
Journal Article -
3
Measles Virus Genotyping by Nucleotide-Specific Multiplex PCR
Published in Journal of Clinical Microbiology (01-07-2004)“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
4
Glioma proteomics: Status and perspectives
Published in Journal of proteomics (10-09-2010)“…High grade gliomas are the most common brain tumors in adults and their malignant nature makes them the fourth biggest cause of cancer death. Major efforts in…”
Get full text
Journal Article -
5
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
Published in Acta neuropathologica (01-01-2015)“…Anti-angiogenic therapy in glioblastoma (GBM) has unfortunately not led to the anticipated improvement in patient prognosis. We here describe how human GBM…”
Get full text
Journal Article -
6
Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)
Published in Molecular & cellular proteomics (01-02-2016)“…Glioblastoma (GBM) is a highly aggressive primary brain tumor with dismal outcome for affected patients. Because of the significant neo-angiogenesis exhibited…”
Get full text
Journal Article -
7
Effects of the Endocrine Disruptors Atrazine and PCB 153 on the Protein Expression of MCF-7 Human Cells
Published in Journal of proteome research (04-12-2009)“…Polychlorinated biphenyls (PCBs) and a number of pesticides can act as endocrine disrupting compounds (EDCs). These molecules exhibit hormonal activity in…”
Get full text
Journal Article -
8
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma
Published in Nature cell biology (01-12-2015)“…L -Glutamine (Gln) functions physiologically to balance the carbon and nitrogen requirements of tissues. It has been proposed that in cancer cells undergoing…”
Get full text
Journal Article -
9
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
Published in Neuro-oncology (Charlottesville, Va.) (01-09-2013)“…Deregulated growth factor signaling is a major driving force in the initiation and progression of glioblastoma. The tumor suppressor and stem cell marker Lrig1…”
Get full text
Journal Article -
10
METB-09IDENTIFYING NOVEL VULNERABILITIES IN OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT GLIOMA
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2015)Get full text
Journal Article -
11
Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas
Published in Neuro-oncology advances (01-01-2021)“…Abstract Background Mutations in isocitrate dehydrogenase 1 or 2 (IDH1/2) define glioma subtypes and are considered primary events in gliomagenesis, impacting…”
Get full text
Journal Article -
12
Atrazine and PCB 153 and their effects on the proteome of subcellular fractions of human MCF-7 cells
Published in Biochimica et biophysica acta (01-06-2012)“…Several man-made organic pollutants including polychlorinated biphenyls (PCBs) and several pesticides may exhibit endocrine disrupting (ED) properties. These…”
Get full text
Journal Article -
13
FSMP-07. CYSTATHIONINE-Γ-LYASE DRIVES ANTIOXIDANT DEFENSE IN CYSTEINE-RESTRICTED IDH1 MUTANT ASTROCYTOMAS
Published in Neuro-oncology advances (25-03-2021)“…Abstract Mutations in isocitrate dehydrogenase 1 or 2 (IDH1/2) define glioma subtypes and are considered primary events in gliomagenesis, impacting tumor…”
Get full text
Journal Article -
14
Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture
Published in Proteome science (11-07-2014)“…Organotypic tumor spheroids, a 3D in vitro model derived from patient tumor material, preserve tissue heterogeneity and retain structural tissue elements, thus…”
Get full text
Journal Article -
15
-
16
Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines
Published in Omics (Larchmont, N.Y.) (01-06-2012)“…Due to high prevalence and slow progression of prostate cancer, primary prevention appears to be attractive strategy for its eradication. During the last…”
Get more information
Journal Article -
17
Cortisol is a potent modulator of lipopolysaccharide-induced interferon signaling in macrophages
Published in Innate immunity (London, England) (01-06-2011)“…The effects of cortisol (CORT) on resting and lipopolysaccharide (LPS)-activated monocyte-derived THP-1 macrophages were investigated by proteomics…”
Get more information
Journal Article -
18
Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG
Published in Acta neuropathologica communications (29-05-2013)“…Point mutations in genes encoding NADP+-dependent isocitrate dehydrogenases (especially IDH1) are common in lower grade diffuse gliomas and secondary…”
Get full text
Journal Article -
19
Low Genetic Diversity despite Hyperendemicity of Hepatitis B Virus Genotype E throughout West Africa
Published in The Journal of infectious diseases (15-07-2004)“…Sub-Saharan Africa suffers from an excessively high endemicity of hepatitis B virus (HBV), but little is known about the prevalent genotypes. In this study, we…”
Get full text
Journal Article -
20
IN SITU METABOLIC PROFILING SHEDS LIGHT ON OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT OLIGODENDROGLIOMA
Published in Neuro-oncology (Charlottesville, Va.) (01-07-2014)“…BACKGROUND: The oncometabolite D-2-hydroxyglutarate (2-HG) is strongly increased in glial tumors presenting a heterozygous point mutation in isocitrate…”
Get full text
Journal Article